Anna Jeter

Anna Jeter serves as the Chief Regulatory Officer and Co-Founder, notably recognized on Inc. Magazine’s 2022 Female Founders 100 List for her contributions to healthcare innovation. She has been instrumental in developing the GlycoLocateTM platform, a significant advancement in early cancer detection. Her expertise extends to managing regulatory processes, having successfully overseen the inclusion of multiple products into national and pan-European healthcare guidelines. Anna’s experience is particularly strong in US FDA submissions, encompassing 510(k), PMA, and CLIA LTD regulatory routes. She has also led teams that launched groundbreaking diagnostics in women’s health across diverse regions including Europe, the Middle East, Latin America, and Asia, significantly impacting the field.